Novel des-γ-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Novel des-γ-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma

Published:2013-07-22 Issue:8 Volume:28 Page:1348-1355
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Tanaka Takahiro¹,Taniguchi Tatsuya¹,Sannomiya Katsutaka¹,Takenaka Hidetaka¹,Tomonari Tetsu¹,Okamoto Koichi¹,Kitamura Shinji¹,Okahisa Toshiya¹,Tamaki Katsuyoshi¹,Mikasa Hiroaki²,Suzuki Sadao³,Takayama Tetsuji¹

Affiliation:

1. Department of Gastroenterology and Oncology; Institutes of Health Biosciences; University of Tokushima Graduate School; Tokushima Japan

2. Medical Education Support Center; Faculty of Medicine; Tokushima University; Tokushima Japan

3. Department of Public Health; Nagoya City University Graduate School of Medical Sciences; Nagoya Japan

Funder

University of Tokushima Graduate School

EIDIA Co, Ltd

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12166/fullpdf

Reference27 articles.

1. Des-gamma-carboxy (abnormal) prothrombinas a serum marker of primary hepatocellular carcinoma;Liebman;N. Engl. J. Med.,1984

2. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients;Marrero;Hepatology,2003

3. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC;Yamamoto;J. Gastroenterol.,2010

4. Des-gamma-carboxyprothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma;Lok;Gastroenterology,2010

5. A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma;Soulier;Gastroenterology,1986

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2023-08-01

2. Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis;Biomedicines;2023-06-28

3. Identification and validation of circulating biomarkers for detection of liver cancer with antibody array;Neoplasma;2023

4. Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study;iLIVER;2022-12

5. The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-Analysis;Current Cancer Drug Targets;2021-09-01